All posts

YEXT is still undervalued, Roth says

Ahead of the company’s second quarter results, Roth MKM analyst Rohit Kulkarni says buy YEXT (YEXT Stock Quote, Chart, News, Analysts, Financials NYSE:YEXT)

On Wednesday, September 6, YEXT will report its Q2, 2024 results.

The analyst says that despite already being up 38 per cent this year, the company has room for more.

“We believe that following recent layoffs, Yext’s completely revamped C-suite is ready to fire on all cylinders,” the analyst argued. “Yext has attractive cash & cash flow characteristics, >20% market cap in cash today, and is likely to generate >$50mn in FCF in 2024. Yext is a play on enterprise adoption
of Gen AI tools to improve worker productivity across marketing and other workflows. Notably, in its 1Q earnings report, Yext highlighted the return of several “boomerang” clients, indicating former customers re-engaging with the platform. Also, Yext is well-positioned for cross- and up-sell opportunities, with 76% of direct customers already utilizing 1 or 2 products.

In a research update to clients September 1, Kulkarni maintained his “Buy” rating and one-year price target of $12.50 on YEXT.

The analyst thinks YEXT will generate EPS of $0.25 on revenue of $406.8-million in fiscal 2024.

“Our price target of $12.50 is based on applying 3.0x ‘CY ’24E Revs and 22.0x CY ’24E EBITDA. Impediments to our price target include a deeper-than-expected economic downturn, the departure of senior execs at the company, or heightened competitive pressure from large tech companies,” Kulkarni concluded.

Tagged with: yext
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELLSTAR could be a shining star for WELL Health, Stifel says

Stifel Research analyst Justin Keywood maintained a “Buy” rating on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News,… [Read More]

15 hours ago

Zimmer Biomet wins price target raise at Roth

Roth Capital Markets analyst Jason Wittes raised his price target on Zimmer Biomet Holdings (Zimmer Biomet Holdings Stock Quote, Chart,… [Read More]

16 hours ago

Beacon Securities comments on Hydreight Technologies pharmacy partnership

Beacon Securities analyst Gabriel Leung noted in a July 14 update that Hydreight Technologies (Hydreight Technologies Stock Quote, Chart, News,… [Read More]

17 hours ago

Is DoorDash stock a buy right now?

Roth Capital Markets analyst Rohit Kulkarni raised his 12-month price target on DoorDash (DoorDash Stock Quote, Chart, News, Analysts, Financials… [Read More]

22 hours ago

Uber earns price target raise at Roth Capital

Roth Capital Markets analyst Rohit Kulkarni raised his price target on Uber (Uber Technologies Stock Quote, Chart, News, Analysts, Financials… [Read More]

22 hours ago

Thermal Energy International is a buy, Beacon says

Beacon Securities analyst Russell Stanley maintained a “Buy” rating and $0.30 target price for Thermal Energy International (Thermal Energy International… [Read More]

2 days ago